Chargement en cours...
Demonstration that fbiC Is Required by Mycobacterium bovis BCG for Coenzyme F(420) and FO Biosynthesis
Using the nitroimidazopyran-based antituberculosis drug PA-824 as a selective agent, transposon-generated Mycobacterium bovis strain BCG (M. bovis) mutants that could not make coenzyme F(420) were identified. Four independent mutants that could not make F(420) or the biosynthesis intermediate FO wer...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2002
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC134996/ https://ncbi.nlm.nih.gov/pubmed/11948155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JB.184.9.2420-2428.2002 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|